TELMISARTAN JL telmisartan 40 mg tablets blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

telmisartan, Quantity: 40 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: sodium hydroxide; povidone; meglumine; mannitol; magnesium stearate

Via di somministrazione:

Oral

Confezione:

56 tablets, 14 tablets, 28 tablets, 30 tablets, 7 tablets (sample), 98 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Telmisartan is indicated for: Treatment of hypertension. Prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see CLINICAL TRIALS).

Dettagli prodotto:

Visual Identification: White to off-white, oblong, un-coated tablets about 11.90 mm in length, 5.80mm width with 'C' debossed on one side and '04' debossed on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2019-03-14